NVCT Financials

Nuvectis Pharma Inc - Financial statements & key metrics

Stock Price

$23.45

Market Cap

$304.51M

P/E Ratio

-21.1

EPS

$-1.37

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-19.00M

EPS (Diluted)

$-1.11

Balance Sheet Highlights

Total Assets

$18.61M

Total Liabilities

$8.89M

Shareholders Equity

Cash & Equivalents

$18.53M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-12.25M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-145.0%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is NVCT revenue?

View NVCT's income statement for detailed revenue data.

Is NVCT profitable?

NVCT reported a loss of $19.00M in the most recent quarter.

What is NVCT market cap?

NVCT has a market capitalization of $304.51M, making it a small-cap stock.

Does NVCT have debt?

View NVCT's balance sheet for debt information.

What is NVCT cash flow?

Cash flow data is available in the full financial statements.